|
Sinovial H-L Group (n = 55)
|
Triamcinolone Group (n = 45)
|
Difference in change scores between groups
|
---|
T0
|
T4
|
Change
|
T0
|
T4
|
Change
| |
---|
Duration of morning stiffness (minutes)
|
Mean ± SD
|
9.73 ± 11.78
|
3.98 ± 5.21
|
−5.75 ± 9.45
|
8.85 ± 4.13
|
8.2 ± 3.94
|
−0.65 ± 2.94
|
−5.10***
|
Range
|
0–60
|
0–20
|
−40 − 5
|
0–15
|
0–15
|
-5-5
| |
SF-36 PCS
|
Mean ± SD
|
35.93 ± 9.52
|
46.51 ± 7.28
|
10.57 ± 9.66
|
38.32 ± 8.71
|
39.94 ± 7.63
|
1.62 ± 3.12
|
8.95***
|
Range
|
20.37–51.41
|
30.98–58.81
|
−11.45-25.07
|
20.43–54.03
|
22.88–54.1
|
−3.72-8.51
| |
SF-36 MCS
|
Mean ± SD
|
50.41 ± 7.68
|
52.23 ± 9.11
|
1.81 ± 10.14
|
41.36 ± 9.52
|
41.7 ± 9.36
|
0.34 ± 2.48
|
1.47*
|
Range
|
34.95–65.58
|
36.4–65.28
|
−15.84-19.55
|
17.21–56.32
|
16.13–56.09
|
−5.07-4.89
| |
- *p < 0.05; ***p < 0.001 Wilcoxon rank-sum test
- SF-36 PCS: Physical Components Summary, SF-36 MCS: Mental Component Summary; T0: time of the first injection; T4: month 6